Phaseline

Companies › Insud Pharma

Insud Pharma: clinical trials, targets and expected readouts

3 active drug programs in 5 registered trials: 2 Phase 3, 2 Phase 4, 1 Phase 1; Infectious disease, Metabolic and endocrine; next expected readout Feb 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Drospirenone (LF111)
Mineralocorticoid receptor antagonist; Progesterone receptor agonist
NR3C2, PGRPhase 4Change in Bone Mineral Density; ContraceptionDec 2027
Albendazole-Ivermectin fixed dose combination (FDC)
Dual antihelmintic fixed dose combination for soil-transmitted helminth treatment
–Phase 3Soil-Transmitted HelminthsFeb 2027
Benznidazole
Antiparasitic agent for Trypanosoma cruzi infection
–Phase 3Chagas DiseaseAug 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06345560Drospirenone (LF111)Phase 1ContraceptionMetabolic and endocrineJul 2026
NCT06282315Albendazole-Ivermectin fixed dose combination (FDC)Phase 3Soil-Transmitted HelminthsInfectious diseaseFeb 2027
NCT04024163BenznidazolePhase 3Chagas DiseaseInfectious diseaseAug 2027
NCT05303636Drospirenone (LF111)Phase 4Change in Bone Mineral DensityMetabolic and endocrineDec 2027
NCT05303636Drospirenone (LF111)Phase 4Change in Bone Mineral DensityMetabolic and endocrineDec 2027

Targets

NR3C2 (1) PGR (1)

Companies with the same targets

Bayer Santhera Pharmaceuticals Calla Lily Clinical Care Changchun GeneScience Pharmaceutical

Companies built like this

Labo'Life Alimera Sciences Laboratorio Farmaceutico SIT srl Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) Jiangxi Qingfeng Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.